Authors: Friesen, RW

Citation: Rw. Friesen, Generation and reactivity of alpha-metalated vinyl ethers, J CHEM S P1, (17), 2001, pp. 1969-2001

Authors: Chauret, N Yergey, JA Brideau, C Friesen, RW Mancini, J Riendeau, D Silva, J Styhler, A Trimble, LA Nicoll-Griffith, DA

Citation: N. Chauret et al., In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663), BIOORG MED, 11(8), 2001, pp. 1059-1062

Authors: Riendeau, D Percival, MD Brideau, C Charleson, S Dube, D Ethier, D Falgueyret, JP Friesen, RW Gordon, R Greig, G Guay, J Mancini, J Ouellet, M Wong, E Xu, L Boyce, S Visco, D Girard, Y Prasit, P Zamboni, R Rodger, IW Gresser, M Ford-Hutchinson, AW Young, RN Chan, CC

Citation: D. Riendeau et al., Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2, J PHARM EXP, 296(2), 2001, pp. 558-566

Authors: Skorey, KI Kennedy, BP Friesen, RW Ramachandran, C

Citation: Ki. Skorey et al., Development of a robust scintillation proximity assay for protein tyrosinephosphatase 1B using the catalytically inactive (C215S) mutant, ANALYT BIOC, 291(2), 2001, pp. 269-278

Authors: Dube, D Brideau, C Deschenes, D Fortin, R Friesen, RW Gordon, R Girard, Y Riendeau, D Savoie, C Chan, CC

Citation: D. Dube et al., 2-heterosubstituted-3-(4-methylsulfonyl)phenyl-5-trifluoromethyl pyridinesas selective and orally active cyclooxygenase-2 inhibitors, BIOORG MED, 9(12), 1999, pp. 1715-1720

Authors: Desmarais, S Friesen, RW Zamboni, R Ramachandran, C

Citation: S. Desmarais et al., [Difluro(phosphono)methyl]phenylalanine-containing peptide inhibitors of protein tyrosine phosphatases, BIOCHEM J, 337, 1999, pp. 219-223